Literature DB >> 23480136

In vitro three-dimensional tumor microenvironment models for anticancer drug discovery.

Keiran Sm Smalley1, Mercedes Lioni, Kazuhiro Noma, Nikolas K Haass, Meenhard Herlyn.   

Abstract

Anticancer drug discovery has long been hampered by the poor predictivity of the preclinical models. There is a growing realization that the tumor microenvironment is a critical determinant of the response of cancer cells to therapeutic agents. The past 5 years have seen a great deal of progress in our understanding of how the three-dimensional microenvironment modulates the signaling behavior of tumor cells. The present review discusses how three-dimensional in vitro cell culture models can benefit cancer drug discovery through an accurate modeling of the tumor microenvironment, leading to more physiologically relevant experimental outcomes.

Entities:  

Year:  2008        PMID: 23480136     DOI: 10.1517/17460441.3.1.1

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  37 in total

1.  Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?

Authors:  Nikolas K Haass
Journal:  Melanoma Manag       Date:  2015-05-18

Review 2.  Model Systems for the Study of Malignant Melanoma.

Authors:  Randal K Gregg
Journal:  Methods Mol Biol       Date:  2021

3.  Modeling nasopharyngeal carcinoma in three dimensions.

Authors:  Prabu Siva Sankar; Mohd Firdaus Che Mat; Kalaivani Muniandy; Benedict Lian Shi Xiang; Phang Su Ling; Susan Ling Ling Hoe; Alan Soo-Beng Khoo; Nethia Mohana-Kumaran
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

4.  Establishment and Analysis of the 3-dimensional (3D) Spheroids Generated from the Nasopharyngeal Carcinoma Cell Line HK1.

Authors:  Kalaivani Muniandy; Prabu Siva Sankar; Benedict Lian Shi Xiang; Alan Khoo Soo-Beng; Venugopal Balakrishnan; Nethia Mohana-Kumaran
Journal:  Trop Life Sci Res       Date:  2016-11

Review 5.  Melanoma and the tumor microenvironment.

Authors:  Jessie Villanueva; Meenhard Herlyn
Journal:  Curr Oncol Rep       Date:  2008-09       Impact factor: 5.075

6.  Imaging- and Flow Cytometry-based Analysis of Cell Position and the Cell Cycle in 3D Melanoma Spheroids.

Authors:  Kimberley A Beaumont; Andrea Anfosso; Farzana Ahmed; Wolfgang Weninger; Nikolas K Haass
Journal:  J Vis Exp       Date:  2015-12-28       Impact factor: 1.355

7.  Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma.

Authors:  Vito W Rebecca; Renato R Massaro; Inna V Fedorenko; Vernon K Sondak; Alexander R A Anderson; Eunjung Kim; Ravi K Amaravadi; Silvya S Maria-Engler; Jane L Messina; Geoffrey T Gibney; Ragini R Kudchadkar; Keiran S M Smalley
Journal:  Pigment Cell Melanoma Res       Date:  2014-02-21       Impact factor: 4.693

8.  Rhenium complexes with visible-light-induced anticancer activity.

Authors:  Anja Kastl; Sandra Dieckmann; Kathrin Wähler; Timo Völker; Lena Kastl; Anna Lena Merkel; Adina Vultur; Batool Shannan; Klaus Harms; Matthias Ocker; Wolfgang J Parak; Meenhard Herlyn; Eric Meggers
Journal:  ChemMedChem       Date:  2013-04-08       Impact factor: 3.466

9.  Decitabine limits escape from MEK inhibition in uveal melanoma.

Authors:  Jessica Gonçalves; Michael F Emmons; Fernanda Faião-Flores; Andrew E Aplin; J William Harbour; Jonathan D Licht; Márcia R Wink; Keiran S M Smalley
Journal:  Pigment Cell Melanoma Res       Date:  2019-12-06       Impact factor: 4.693

Review 10.  Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer.

Authors:  Bryan E Strauss; Gissele Rolemberg Oliveira Silva; Igor de Luna Vieira; Otto Luiz Dutra Cerqueira; Paulo Roberto Del Valle; Ruan Felipe Vieira Medrano; Samir Andrade Mendonça
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.